Jean Genève

4.3k total citations · 1 hit paper
54 papers, 3.1k citations indexed

About

Jean Genève is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Jean Genève has authored 54 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Jean Genève's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Cancer Treatment and Pharmacology (8 papers). Jean Genève is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Cancer Treatment and Pharmacology (8 papers). Jean Genève collaborates with scholars based in France, United States and Luxembourg. Jean Genève's co-authors include Jean‐Pierre Pignon, Laurent Bedenne, Thierry Conroy, B. Saint‐Aubert, P Lasser, Olivier Bouché, Valérie Boige, Marc Ychou, G. Lebreton and P. Rougier and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Jean Genève

52 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

2011 1.5k citations Marc Ychou, Valérie Boige et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jean Genève

Since Specialization

Citations

This map shows the geographic impact of Jean Genève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Genève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Genève more than expected).

Fields of papers citing papers by Jean Genève

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Genève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Genève. The network helps show where Jean Genève may publish in the future.

Co-authorship network of co-authors of Jean Genève

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Genève. A scholar is included among the top collaborators of Jean Genève based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Genève. Jean Genève is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial breakdown → 2011 ·Journal of Clinical Oncology ·Marc Ychou, Valérie Boige, Jean‐Pierre Pignon, Thierry Conroy, Olivier Bouché, G. Lebreton, (unknown), Laurent Bedenne, (unknown), B. Saint‐Aubert, Jean Genève, P Lasser, P. Rougier	1484
2	Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial 2010 ·Critical Reviews in Oncology/Hematology ·Étienne Brain, C. Mertens, Véronique Girre, Frédérique Rousseau, Emmanuel Blot, (unknown), Lionel Uwer, Emmanuelle Bourbouloux, (unknown), Loı̈c Mourey, Sylvie Kirscher, Brigitte Laguerre, Emmanuelle Fourme, (unknown), Jean Genève, Marc Debled	38
3	Participants’ uptake of clinical trial results: a randomised experiment 2010 ·British Journal of Cancer ·Julien Mancini, Dominique Genre, Florence Dalenc, Jean-Marc Ferrero, Pierre Kerbrat, Anne‐Laure Martin, Henri Roché, F May-Levin, Carole Tarpin, Patrice Viens, Jean Genève, (unknown)	15
4	Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO) 2010 ·Critical Reviews in Oncology/Hematology ·Frédérique Rousseau, F. Rétornaz, Florence Joly, Benjamin Esterni, Sophie Abadie‐Lacourtoisie, P. Fargeot, É. Luporsi, V. Servent, Brigitte Laguerre, Étienne Brain, Jean Genève	9
5	Effect of XELOX on functional ability among elderly patients with metastatic colorectal cancer: Results from the FNCLCC/GERICO 02 phase II study 2010 ·Journal of Geriatric Oncology ·Frédérique Rousseau, R. Bugat, Michel Ducreux, F. Cvitkovic, Élisabeth Carola, Mathilde Gisselbrecht, F. Viret, Benjamin Esterni, Jean Genève, Étienne Brain	0
6	A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial 2008 ·Breast Cancer Research and Treatment ·Pascal Jézéquel, Mario Campone, Henri Roché, Wilfried Gouraud, Catherine Guérin‐Charbonnel, Gabriel Ricolleau, Florence Magrangeas, Stéphane Minvielle, Jean Genève, Anne‐Laure Martin, Régis Bataille, L. Campion	11
7	Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01 2007 ·Journal of Clinical Oncology ·Jean Louis Pujol, (unknown), Radj Gervais, Marie‐Laure Tanguy, Élisabeth Quoix, Philippe David, Henri Janicot, Virginie Westeel, (unknown), Jean Genève, D Maraninchi	97
8	Un outil de suivi et d’auto-évaluation du bon usage du médicament en cancérologie : l’observatoire du médicament de la FNCLCC 2007 ·Journal de Pharmacie Clinique ·(unknown), (unknown), Jean Genève, (unknown)	1
9	Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen 2007 ·Breast Cancer Research and Treatment ·Mario Campone, L. Campion, (unknown), Wilfried Gouraud, Catherine Guérin‐Charbonnel, Florence Magrangeas, Stéphane Minvielle, Jean Genève, Anne‐Laure Martin, Régis Bataille, Pascal Jézéquel	34
10	Constitution d'un catalogue commun à plusieurs CRLCC 2006 ·médecine/sciences ·(unknown), Jean Genève	0
11	Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol 2006 ·Bone Marrow Transplantation ·(unknown), Patricia Pautier, Frédèric Selle, Patrice Viens, Michel Fabbro, François Lokiec, F. Viret, Joseph Gligorov, (unknown), S. Provent, Vincent Ribrag, (unknown), Christine Dosquet, (unknown), (unknown), Guillaume Lefèvre, Jean Genève, C. Lhommé, (unknown)	3
12	Validation of a specific quality of life questionnaire for functional digestive disorders 1999 ·Gut ·Olivier Chassany, Patrick Marquis, Bruno Scherrer, N W Read, Thomas E. Finger, Jean‐François Bergmann, B Fraitag, Jean Genève, (unknown)	138
13	Inhibition of prostaglandin-induced intestinal secretion by igmesine in healthy volunteers 1998 ·Gastroenterology ·C Rozé, Stanislas Bruley des Varannes, Guoxiang Shi, Jean Genève, Jean Paul Galmiche	18
14	Peptide YY inhibition of prostaglandin-induced intestinal secretion is haloperidol-sensitive in humans 1997 ·Gastroenterology ·C Rozé, C Molis, (unknown), Alain Ropert, Jean Genève, J P Galmiche	17
15	Fedotozine in irritable bowel syndrome: Results of a 6 wk placebo-controlled multicenter therapeutic trial 1995 ·Gastroenterology ·Michel Dapoigny, Jean‐Louis Abitbol, (unknown), Jean Genève, B Fraitag	5
16	Theophylline steady state pharmacokinetics is not altered by omeprazole 1992 ·European Journal of Clinical Pharmacology ·Anne Marie Taburet, Jean Genève, (unknown), Guy G. Simoneau, C Caulin, E Singlas	17
17	Effect of psychological stress on gastric potential difference in man. 1991 ·PubMed ·Jean‐François Bergmann, Carlos Caulı́n, Jean Genève, Guy G. Simoneau, (unknown)	1
18	Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis 1990 ·Journal of Hepatology ·Jean Genève, (unknown), Didier Mathieu, Élie Serge Zafrani, Daniel Dhumeaux, Jean‐Michel Métreau	5
19	Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects. 1990 ·British Journal of Clinical Pharmacology ·Jean Genève, (unknown), (unknown), (unknown), (unknown), C Caulin	6
20	Cross hepatotoxicity between tricyclic antidepressants. 1986 ·Gut ·Dominique Larrey, B Rueff, Dominique Pessayre, (unknown), (unknown), Jean Genève, J P Benhamou	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact